The Alzheimer's treatment landscape presents a compelling opportunity for investors in healthcare and biotech. Alzheimer's disease is a progressive and debilitating neurodegenerative disorder that poses a significant and growing threat to global health and economic well-being. With an estimated 6.7 million Americans currently living with Alzheimer's and projected costs exceeding $2 trillion over the next decade, the urgency for effective treatments is undeniable. This unmet medical need has created an arena ...